Neuregulin-1 Reverses Long-Term Potentiation at CA1 Hippocampal Synapses

Neuregulin-1 (NRG-1) has been identified genetically as a schizophrenia susceptibility gene, but its function in the adult brain is unknown. Here, we show that NRG-1β does not affect basal synaptic transmission but reverses long-term potentiation (LTP) at hippocampal Schaffer collateral→CA1 synapses in an activity- and time-dependent manner. Depotentiation by NRG-1β is blocked by two structurally distinct and selective ErbB receptor tyrosine kinase inhibitors. Moreover, ErbB receptor inhibition increases LTP at potentiated synapses and blocks LTP reversal by theta-pulse stimuli. NRG-1β selectively reduces AMPA, not NMDA, receptor EPSCs and has no effect on paired-pulse facilitation ratios. Live imaging of hippocampal neurons transfected with receptors fused to superecliptic green fluorescent protein, as well as quantitative analysis of native receptors, show that NRG-1β stimulates the internalization of surface glutamate receptor 1-containing AMPA receptors. This novel regulation of LTP by NRG-1 has important implications for the modulation of synaptic homeostasis and schizophrenia.

[1]  Zhen Yan,et al.  Regulation of NMDA Receptors by Neuregulin Signaling in Prefrontal Cortex , 2005, The Journal of Neuroscience.

[2]  M. Daly,et al.  Support for involvement of neuregulin 1 in schizophrenia pathophysiology , 2005, Molecular Psychiatry.

[3]  Paul J. Harrison,et al.  Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain , 2004, Neuroscience.

[4]  J. Montgomery,et al.  Discrete synaptic states define a major mechanism of synapse plasticity , 2004, Trends in Neurosciences.

[5]  M. Bear,et al.  LTP and LTD An Embarrassment of Riches , 2004, Neuron.

[6]  G. Lynch,et al.  A Novel Mechanism for the Facilitation of Theta-Induced Long-Term Potentiation by Brain-Derived Neurotrophic Factor , 2004, The Journal of Neuroscience.

[7]  J. Buxbaum,et al.  Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia , 2004, Nature Neuroscience.

[8]  W. Hulstijn,et al.  Drug-induced stimulation and suppression of action monitoring in healthy volunteers , 2004, Psychopharmacology.

[9]  J. Henley,et al.  It's green outside: tracking cell surface proteins with pH-sensitive GFP , 2004, Trends in Neurosciences.

[10]  A. Buonanno,et al.  Neuregulin‐2 is developmentally regulated and targeted to dendrites of central neurons , 2004, The Journal of comparative neurology.

[11]  Paul J. Harrison.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications , 2004, Psychopharmacology.

[12]  C. McBain,et al.  Two Loci of Expression for Long-Term Depression at Hippocampal Mossy Fiber-Interneuron Synapses , 2004, The Journal of Neuroscience.

[13]  R Hashimoto,et al.  Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia , 2004, Molecular Psychiatry.

[14]  H. Stefánsson,et al.  Neuregulin 1 and schizophrenia , 2004, Annals of medicine.

[15]  J. Coyle,et al.  Glutamatergic mechanisms in schizophrenia. , 2003, Annual review of pharmacology and toxicology.

[16]  S. Carroll,et al.  Neuregulin–1 and ErbB4 Immunoreactivity Is Associated with Neuritic Plaques in Alzheimer Disease Brain and in a Transgenic Model of Alzheimer Disease , 2003, Journal of neuropathology and experimental neurology.

[17]  Gary Lynch,et al.  Long-term potentiation alters the modulator pharmacology of AMPA-type glutamate receptors. , 2002, Journal of neurophysiology.

[18]  B. Sakmann,et al.  Molecular dissection of hippocampal theta-burst pairing potentiation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  G. Fischbach,et al.  Neuregulin Expression at Neuromuscular Synapses Is Modulated by Synaptic Activity and Neurotrophic Factors , 2002, The Journal of Neuroscience.

[20]  Jacques Noël,et al.  Transient synaptic activation of NMDA receptors leads to the insertion of native AMPA receptors at hippocampal neuronal plasma membranes , 2001, Neuropharmacology.

[21]  R. Huganir,et al.  Activation of Silent Synapses by Rapid Activity-Dependent Synaptic Recruitment of AMPA Receptors , 2001, The Journal of Neuroscience.

[22]  G. Fischbach,et al.  Neuregulin and ErbB receptor signaling pathways in the nervous system , 2001, Current Opinion in Neurobiology.

[23]  A. Buonanno,et al.  Erbb transmembrane tyrosine kinase receptors are differentially expressed throughout the adult rat central nervous system , 2001, The Journal of comparative neurology.

[24]  Wei-Yang Lu,et al.  Activation of Synaptic NMDA Receptors Induces Membrane Insertion of New AMPA Receptors and LTP in Cultured Hippocampal Neurons , 2001, Neuron.

[25]  D. Yang,et al.  Regulation of Neuregulin Signaling by PSD-95 Interacting with ErbB4 at CNS Synapses , 2000, Neuron.

[26]  A. Buonanno,et al.  The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Cary Lai,et al.  Role of neuregulins in glial cell development , 2000, Glia.

[28]  R. Nicoll,et al.  Expression Mechanisms Underlying NMDA Receptor‐Dependent Long‐Term Potentiation , 1999, Annals of the New York Academy of Sciences.

[29]  M. Sliwkowski,et al.  Binding specificities and affinities of egf domains for ErbB receptors , 1999, FEBS letters.

[30]  M. Bear,et al.  Metaplasticity: the plasticity of synaptic plasticity , 1996, Trends in Neurosciences.

[31]  U. Staubli,et al.  Factors regulating the reversibility of long-term potentiation , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  B. Alger,et al.  GABAergic and developmental influences on homosynaptic LTD and depotentiation in rat hippocampus , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[33]  G. Brewer,et al.  Optimized survival of hippocampal neurons in B27‐supplemented neurobasal™, a new serum‐free medium combination , 1993, Journal of neuroscience research.

[34]  T. Bliss,et al.  A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.

[35]  S. Purcell,et al.  Support for involvement of neuregulin 1 in schizophrenia pathophysiology , 2005, Molecular Psychiatry.

[36]  Paul J. Harrison,et al.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence , 2005, Molecular Psychiatry.

[37]  K. Hsu,et al.  Progress in Understanding the Factors Regulating Reversibility of Long-term Potentiation , 2001, Reviews in the neurosciences.

[38]  G. Fischbach,et al.  ARIA: a neuromuscular junction neuregulin. , 1997, Annual review of neuroscience.

[39]  B. Alger,et al.  Homosynaptic LTD and depotentiation: Do they differ in name only? , 1996, Hippocampus.

[40]  D. Stuss,et al.  Cognitive neuroscience. , 1993, Current opinion in neurobiology.